Ilhan-Mutlu, Aysegul https://orcid.org/0000-0001-8291-0873
Article History
Accepted: 9 October 2024
First Online: 29 November 2024
Conflict of interest
: A. Ilhan-Mutlu declares advisory role: MSD, Servier, Daiichi Sankyo, BMS and Astellas; consulting: Astellas, MSD, Amgen, Astra Zeneca, BeiGene, Verdi and Roche; lecture honoraria: Eli Lilly, Servier, BMS, Daiichi Sankyo, Astellas, Astra Zeneca and MSD; travel support: BMS, Roche, Eli Lilly, Daiichi Sankyo and BeiGene.
Free to read: This content has been made available to all.